These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 30714541)

  • 21. Agitation-associated behavioral symptoms in mild cognitive impairment and Alzheimer's dementia.
    Van der Mussele S; Le Bastard N; Saerens J; Somers N; Mariën P; Goeman J; De Deyn PP; Engelborghs S
    Aging Ment Health; 2015; 19(3):247-57. PubMed ID: 24962058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer's disease.
    Trzepacz PT; Yu P; Bhamidipati PK; Willis B; Forrester T; Tabas L; Schwarz AJ; Saykin AJ;
    Alzheimers Dement; 2013 Oct; 9(5 Suppl):S95-S104.e1. PubMed ID: 23253778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prazosin for the treatment of behavioral symptoms in patients with Alzheimer disease with agitation and aggression.
    Wang LY; Shofer JB; Rohde K; Hart KL; Hoff DJ; McFall YH; Raskind MA; Peskind ER
    Am J Geriatr Psychiatry; 2009 Sep; 17(9):744-51. PubMed ID: 19700947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A placebo-controlled trial of valproate for agitation and aggression in Alzheimer's disease.
    Herrmann N; Lanctôt KL; Rothenburg LS; Eryavec G
    Dement Geriatr Cogn Disord; 2007; 23(2):116-9. PubMed ID: 17148938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of risperidone on behavioral and psychological symptoms and cognitive function in dementia.
    Rainer MK; Masching AJ; Ertl MG; Kraxberger E; Haushofer M
    J Clin Psychiatry; 2001 Nov; 62(11):894-900. PubMed ID: 11775050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caregiver burden in atypical dementias: comparing frontotemporal dementia, Creutzfeldt-Jakob disease, and Alzheimer's disease.
    Uflacker A; Edmondson MC; Onyike CU; Appleby BS
    Int Psychogeriatr; 2016 Feb; 28(2):269-73. PubMed ID: 26435062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized, double-blind, placebo-controlled trial of memantine in a behaviorally enriched sample of patients with moderate-to-severe Alzheimer's disease.
    Herrmann N; Gauthier S; Boneva N; Lemming OM;
    Int Psychogeriatr; 2013 Jun; 25(6):919-27. PubMed ID: 23472619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality of Life in relation to neuropsychiatric symptoms in Alzheimer's disease: 5-year prospective ALSOVA cohort study.
    Hongisto K; Hallikainen I; Selander T; Törmälehto S; Väätäinen S; Martikainen J; Välimäki T; Hartikainen S; Suhonen J; Koivisto AM
    Int J Geriatr Psychiatry; 2018 Jan; 33(1):47-57. PubMed ID: 28067961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive behavioural treatment for mild Alzheimer's patients and their caregivers (CBTAC): study protocol for a randomized controlled trial.
    Forstmeier S; Maercker A; Savaskan E; Roth T
    Trials; 2015 Nov; 16():526. PubMed ID: 26576633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between dementia severity and behavioural and psychological symptoms in early-onset Alzheimer's disease.
    Tanaka H; Hashimoto M; Fukuhara R; Ishikawa T; Yatabe Y; Kaneda K; Yuuki S; Honda K; Matsuzaki S; Tsuyuguchi A; Hatada Y; Ikeda M
    Psychogeriatrics; 2015 Dec; 15(4):242-7. PubMed ID: 25737233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dependence Levels as Interim Clinical Milestones Along the Continuum of Alzheimer's Disease: 18-Month Results from the GERAS Observational Study.
    Kahle-Wrobleski K; Andrews JS; Belger M; Ye W; Gauthier S; Rentz DM; Galasko D
    J Prev Alzheimers Dis; 2017; 4(2):72-80. PubMed ID: 29186278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors of caregiver burden among patients with Alzheimer's disease or related disorders: a cross-sectional study.
    Dauphinot V; Delphin-Combe F; Mouchoux C; Dorey A; Bathsavanis A; Makaroff Z; Rouch I; Krolak-Salmon P
    J Alzheimers Dis; 2015; 44(3):907-16. PubMed ID: 25374109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Predictors of long-term institutionalization in patients with Alzheimer's disease: role of caregiver burden].
    Hirono N; Tsukamoto N; Inoue M; Moriwaki Y; Mori E
    No To Shinkei; 2002 Sep; 54(9):812-8. PubMed ID: 12428367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Psychotropic Medication on Cognition, Caregiver Burden, and Neuropsychiatric Symptoms in Alzheimer's Disease over 12 Months: Results from a Prospective Registry of Dementia in Austria (PRODEM).
    Pirker-Kees A; Dal-Bianco P; Schmidt R
    J Alzheimers Dis; 2019; 71(2):623-630. PubMed ID: 31424389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Profile of the informal carer associated with the clinical management of the Alzheimer's disease patient refractory to symptomatic treatment of the disease].
    Molinuevo JL; Hernández B;
    Neurologia; 2011 Nov; 26(9):518-27. PubMed ID: 21803459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relative importance of patient disease indicators on informal care and caregiver burden in Alzheimer's disease.
    Bergvall N; Brinck P; Eek D; Gustavsson A; Wimo A; Winblad B; Jönsson L
    Int Psychogeriatr; 2011 Feb; 23(1):73-85. PubMed ID: 20619068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Driving cessation and dementia: results of the prospective registry on dementia in Austria (PRODEM).
    Seiler S; Schmidt H; Lechner A; Benke T; Sanin G; Ransmayr G; Lehner R; Dal-Bianco P; Santer P; Linortner P; Eggers C; Haider B; Uranues M; Marksteiner J; Leblhuber F; Kapeller P; Bancher C; Schmidt R;
    PLoS One; 2012; 7(12):e52710. PubMed ID: 23300746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropsychiatric symptom clusters of Alzheimer disease in Hong Kong Chinese: correlates with caregiver burden and depression.
    Cheng ST; Lam LC; Kwok T
    Am J Geriatr Psychiatry; 2013 Oct; 21(10):1029-37. PubMed ID: 23567373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occurrence of neuropsychiatric symptoms and psychiatric disorders in mild Alzheimer's disease and mild cognitive impairment subtypes.
    Di Iulio F; Palmer K; Blundo C; Casini AR; Gianni W; Caltagirone C; Spalletta G
    Int Psychogeriatr; 2010 Jun; 22(4):629-40. PubMed ID: 20367890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of rivastigmine treatment on the neuropsychiatric and behavioral disturbances of nursing home residents with moderate to severe probable Alzheimer's disease: a 26-week, multicenter, open-label study.
    Cummings JL; Koumaras B; Chen M; Mirski D;
    Am J Geriatr Pharmacother; 2005 Sep; 3(3):137-48. PubMed ID: 16257816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.